All Stories

  1. A thematic analysis of flu vaccine hesitance in ethnically minoritised communities in Liverpool
  2. Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder
  3. Changes in processing speed during early abstinence from alcohol dependence
  4. The Associations among Perceived Courtesy Stigma, Health and Social Behaviours in Family Members and Friends of People Who Use Substances: An Ecological Momentary Assessment Study
  5. Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Systematic review of longitudinal studies
  6. Improving access to treatment for alcohol dependence in primary care: A qualitative investigation of factors that facilitate and impede treatment access and completion
  7. Taking the pain out of pain
  8. Little Evidence for the Role of Disgust Sensitivity in Implicit Disgust to Images of White People Engaged in Injecting Drug Use (IDU)
  9. Younger, drunk, and fast: Paradoxical rapid reaction time in hazardous drinkers
  10. Prevalence and incidence of alcohol dependence: cross-sectional primary care analysis in Liverpool, UK
  11. Opioid prescribing and social deprivation: A retrospective analysis of prescribing for CNCP in Liverpool CCG
  12. Feasibility study of a Behavioural Intervention for Opioid Reduction (BIOR) for patients with chronic non-cancer pain in primary care: a protocol
  13. Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Protocol for a systematic review of longitudinal studies
  14. Subjective executive function deficits in hazardous alcohol drinkers
  15. Moral disengagement and the harms of cocaine use
  16. A pilot study assessing the brain gauge as an indicator of cognitive recovery in alcohol dependence
  17. Age-related prefrontal cortex activation in associative memory: An fNIRS pilot study
  18. Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders
  19. MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users
  20. Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects
  21. Updating of working memory in ecstasy polydrug users: Findings from fNIRS
  22. The Differential Recruitment of Short-Term Memory and Executive Functions during Time, Number, and Length Perception: An Individual Differences Approach
  23. Measures of Bayesian Reasoning Performance on ‘Normal’ and ‘Natural’ Frequency Tasks
  24. Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users
  25. Meta-analysis of executive functioning in ecstasy/polydrug users
  26. The effects of anticipated challenge on indices of diurnal cortisol secretion in recreational users of ecstasy
  27. Cortical oxygenation suggests increased effort during cognitive inhibition in ecstasy polydrug users
  28. fNIRS suggests increased effort during executive access in ecstasy polydrug users
  29. The differential contribution of executive functions to temporal generalisation, reproduction and verbal estimation
  30. MDMA, cortisol, and heightened stress in recreational ecstasy users
  31. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users
  32. Reasoning deficits among illicit drug users are associated with aspects of cannabis use
  33. Temporal and visual source memory deficits among ecstasy/polydrug users
  34. Prospective memory deficits in illicit polydrug users are associated with the average long-term typical dose of ecstasy typically consumed in a single session.
  35. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users
  36. Electrophysiological indices of response inhibition in human polydrug users
  37. ERP evidence suggests executive dysfunction in ecstasy polydrug users
  38. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
  39. Self-reports of Executive Dysfunction in Current Ecstasy/Polydrug Users
  40. Cannabis-related deficits in real-world memory
  41. The effects of ‘ecstasy’ (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses
  42. The effects of heavy social drinking on executive function: a systematic review and meta-analytic study of existing literature and new empirical findings
  43. Effects of ecstasy/polydrug use on memory for associative information
  44. The relationships of ‘ecstasy’ (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory
  45. The effect of alcohol administration on human timing: A comparison of prospective timing, retrospective timing and passage of time judgements
  46. The role of executive functions in human prospective interval timing
  47. COMMENT ON HALPERN ET AL. (2011)
  48. Visuospatial working memory impairment in current and previous ecstasy/polydrug users
  49. The effects of a modest dose of alcohol on executive functioning and prospective memory
  50. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT)
  51. Modelling the adverse effects associated with ecstasy use
  52. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm
  53. Effects of alcohol preload on attentional bias towards cocaine-related cues
  54. Everyday and prospective memory deficits in ecstasy/polydrug users
  55. Sleep Impairment in Ecstasy/Polydrug and Cannabis-Only Users
  56. Sleep Impairment in Ecstasy/Polydrug and Cannabis-Only Users
  57. Executive Working Memory Deficits in Abstinent Ecstasy/MDMA Users: A Critical Review
  58. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
  59. The effects of perceived parenting style on the propensity for illicit drug use: the importance of parental warmth and control
  60. Is emotional intelligence impaired in ecstasy-polydrug users?
  61. Real-world memory and executive processes in cannabis users and non-users
  62. Ecstasy-related deficits in the updating component of executive processes
  63. Evidence for selective executive function deficits in ecstasy/polydrug users
  64. Information processing speed in ecstasy (MDMA) users
  65. Self reported sleep quality and cognitive performance in ecstasy users
  66. Everyday memory deficits in ecstasy-polydrug users
  67. The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?
  68. Reasoning deficits in ecstasy (MDMA) polydrug users
  69. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory
  70. The nature of ecstasy-group related deficits in associative learning
  71. Syllogistic Reasoning Performance in MDMA (Ecstasy) Users.
  72. Visuo-spatial working memory deficits in current and former users of MDMA (?ecstasy?)
  73. Evidence for executive deficits among users of MDMA (Ecstasy)
  74. Verbal working memory deficits in current and previous users of MDMA